{
  "source_attachment": {
    "filename": "megavit_c_ed_low_high(4).jpg",
    "path": ""
  },
  "document": {
    "title_or_product": "MegaVit MultiBoost",
    "summary": "A dietary supplement advertisement featuring a smiling, athletic-looking man apparently running outdoors while holding a bottle of MegaVit MultiBoost. The text claims that, in a randomized, double-blind, placebo-controlled 12-week trial involving 600 adults with low vitamin B12 status, participants receiving the product experienced a greater increase in blood B12 concentrations than those receiving placebo. No study citation, numerical results, dosage, or statistical analysis is provided. The imagery suggests physical vitality, although the stated trial outcome concerns only a blood biomarker."
  },
  "marks": [
    {
      "id": "m01",
      "description": "The advertisement makes a specific and apparently authoritative clinical trial claim, including the study design, duration, sample size, population and favourable comparative outcome, but supplies no identifiable study reference or numerical results. The reader cannot verify that the trial took place as described, determine the size or statistical reliability of the difference, or establish whether the result was clinically meaningful. The phrase 'greater increase' does not establish whether the difference was statistically significant, and the criterion used to define low vitamin B12 status is unspecified. These omissions matter because the trial is the advertisement's principal evidence of product effectiveness.",
      "locations": [
        {
          "text": "In a randomized, double-blind,",
          "bbox": [0.042, 0.249, 0.451, 0.289]
        },
        {
          "text": "placebo-controlled 12-week",
          "bbox": [0.042, 0.297, 0.416, 0.339]
        },
        {
          "text": "trial of 600 adults with low",
          "bbox": [0.042, 0.345, 0.405, 0.388]
        },
        {
          "text": "vitamin B12 status, participants",
          "bbox": [0.042, 0.393, 0.464, 0.437]
        },
        {
          "text": "showed a greater increase in",
          "bbox": [0.042, 0.488, 0.429, 0.533]
        },
        {
          "text": "blood B12 concentrations than",
          "bbox": [0.042, 0.537, 0.455, 0.58]
        },
        {
          "text": "participants receiving placebo.",
          "bbox": [0.042, 0.586, 0.456, 0.628]
        }
      ],
      "assessments": [
        {
          "field": "TATD",
          "score": 0.88,
          "reason": "A substantial, product-specific randomized clinical trial is asserted without an identifiable publication, registry entry or other usable source. The comparative outcome is stated without an effect magnitude, uncertainty estimate, statistical significance information or information sufficient to judge clinical relevance. Although some useful trial-design information is given, the evidence cannot be independently evaluated from the advertisement."
        }
      ],
      "recommendation": "Obtain and verify the underlying trial report or study registration. Supply an identifiable reference, the product dose and relevant formulation, the definition of low B12 status, the numerical B12 changes in both groups, the between-group difference and its uncertainty, and appropriate statistical information. Confirm that the advertised conclusion accurately represents the findings. If the trial cannot be substantiated, remove the specific clinical trial claim.",
      "revised_text": ""
    },
    {
      "id": "m02",
      "description": "The prominent image of a fit, smiling man apparently running while displaying the supplement conveys an impression of enhanced physical vitality, energy and fitness associated with MegaVit MultiBoost. Placed alongside the clinical trial statement, the image may encourage readers to interpret an increase in blood B12 concentration as evidence of improved exercise performance or general vitality. The reported biomarker outcome does not by itself establish such benefits. The image is not inherently objectionable, but its relationship with the scientific claim warrants review.",
      "locations": [
        {
          "text": "",
          "bbox": [0.47, 0.002, 0.892, 0.988]
        },
        {
          "text": "",
          "bbox": [0.356, 0.282, 0.491, 0.681]
        },
        {
          "text": "blood B12 concentrations than",
          "bbox": [0.042, 0.537, 0.455, 0.58]
        }
      ],
      "assessments": [
        {
          "field": "VP",
          "score": 0.88,
          "reason": "The athletic physique, running posture, broad smile, sunlit outdoor setting and prominently displayed supplement together create a strong impression of vigour, fitness and positive physical performance."
        },
        {
          "field": "TATD",
          "score": 0.55,
          "reason": "The only explicit trial outcome concerns blood B12 concentrations in adults with low B12 status. No evidence is presented that participants experienced improved energy, endurance, exercise performance or general physical fitness, as the accompanying imagery could imply."
        }
      ],
      "recommendation": "Review whether the overall combination of image and clinical claim communicates an intended benefit in vitality or physical performance. If it does, obtain appropriate product-specific evidence supporting that benefit, or adjust the imagery or presentation to avoid implying it. There is no need to remove positive lifestyle imagery merely because it depicts a healthy person, provided the overall impression remains consistent with the substantiated claims.",
      "revised_text": ""
    }
  ]
}